Siavash S, Ghaffari A, Taghizadeh G, Lajevardi L, Azad A
J Aging Res. 2025; 2025:9959086.
PMID: 39816625
PMC: 11730014.
DOI: 10.1155/jare/9959086.
Meng C, Lee Y, Schieir O, Valois M, Butler M, Boire G
J Clin Rheumatol. 2024; 30(5):193-199.
PMID: 38689390
PMC: 11388901.
DOI: 10.1097/RHU.0000000000002091.
Delnoij D, Derks M, Koolen L, Shekary S, Suitela J
JMIR Form Res. 2023; 7:e43210.
PMID: 37505797
PMC: 10422175.
DOI: 10.2196/43210.
Mena-Vazquez N, Lisbona-Montanez J, Redondo-Rodriguez R, Mucientes A, Manrique-Arija S, Rioja J
Front Med (Lausanne). 2022; 9:1016159.
PMID: 36425102
PMC: 9679221.
DOI: 10.3389/fmed.2022.1016159.
Ruscitti P, Rozza G, Di Muzio C, Biaggi A, Iacono D, Pantano I
Medicine (Baltimore). 2022; 101(28):e29540.
PMID: 35838988
PMC: 11132363.
DOI: 10.1097/MD.0000000000029540.
Need for Palliative Care in Patient with Rheumatoid Arthritis: A Cross-sectional Observational Study.
Mahendru K, Gupta N, Soneja M, Malhotra R, Kumar V, Garg R
Indian J Palliat Care. 2021; 27(2):275-280.
PMID: 34511796
PMC: 8428903.
DOI: 10.25259/IJPC_395_20.
Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.
Grygiel-Gorniak B
Clin Rheumatol. 2021; 41(1):1-18.
PMID: 34218393
PMC: 8254634.
DOI: 10.1007/s10067-021-05805-5.
The Impacts of and Genetic Variants on Rheumatoid Arthritis Risk in the Chinese Han Population: A Case-Control Study.
Liu X, Peng L, Li D, He C, Xing S, Wang Y
Int J Gen Med. 2021; 14:2147-2159.
PMID: 34093035
PMC: 8169084.
DOI: 10.2147/IJGM.S291395.
Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology.
Salaffi F, Farah S, Di Carlo M
Acta Biomed. 2020; 91(2):274-296.
PMID: 32420963
PMC: 7569610.
DOI: 10.23750/abm.v91i2.9094.
Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression.
Yayikci Y, Karadag A
Eurasian J Med. 2019; 51(1):12-16.
PMID: 30911249
PMC: 6422621.
DOI: 10.5152/eurasianjmed.2018.18018.
The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
Salaffi F, Di Carlo M, Carotti M, Farah S
Pain Res Manag. 2018; 2018:3496846.
PMID: 30425755
PMC: 6218716.
DOI: 10.1155/2018/3496846.
OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?.
Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C
J Rheumatol. 2017; 44(12):1899-1903.
PMID: 28298567
PMC: 6353610.
DOI: 10.3899/jrheum.161112.
Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis.
Janssens X, Decuman S, De Keyser F
PLoS One. 2016; 11(1):e0146688.
PMID: 26800345
PMC: 4723361.
DOI: 10.1371/journal.pone.0146688.
Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009.
Herrinton L, Harrold L, Salman C, Liu L, Goldfien R, Asgari M
Perm J. 2015; 20(1):4-12.
PMID: 26694020
PMC: 4732788.
DOI: 10.7812/TPP/15-028.
Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.
Jiang X, Sandberg M, Saevarsdottir S, Klareskog L, Alfredsson L, Bengtsson C
Arthritis Res Ther. 2015; 17:317.
PMID: 26546562
PMC: 4636760.
DOI: 10.1186/s13075-015-0836-6.
Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey.
Brands M, Gungor D, van den Hout J, Karstens F, Oussoren E, Plug I
J Inherit Metab Dis. 2014; 38(2):323-31.
PMID: 25048386
DOI: 10.1007/s10545-014-9737-0.
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.
Norton S, Fu B, Scott D, Deighton C, Symmons D, Wailoo A
Semin Arthritis Rheum. 2014; 44(2):131-44.
PMID: 24925692
PMC: 4282305.
DOI: 10.1016/j.semarthrit.2014.05.003.
Multi-dimensional health assessment questionnaire in China: reliability, validity and clinical value in patients with rheumatoid arthritis.
Song Y, Zhu L, Wang S, Leng L, Bucala R, Lu L
PLoS One. 2014; 9(5):e97952.
PMID: 24848431
PMC: 4029794.
DOI: 10.1371/journal.pone.0097952.
Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration.
Poulsen C, Jacobsen S, Frisch M, Frederiksen K, Johansen C
Rheumatol Int. 2013; 33(11):2763-72.
PMID: 23812092
DOI: 10.1007/s00296-013-2807-z.
Swedish version of the multi dimensional health assessment questionnaire -- translation and psychometric evaluation.
Areskoug Josefsson K, Ekdahl C, Jakobsson U, Gard G
BMC Musculoskelet Disord. 2013; 14:178.
PMID: 23734791
PMC: 3695768.
DOI: 10.1186/1471-2474-14-178.